Echocardiographic features of patients with COVID-19 infection: a cross-sectional study

Barman, Hasan Ali; c, Adem At; Tekin, Esra Aktaş; baycan, omer; c, G khan Al; Sit, Omer; Gen, mer; Güngör, Barış; Şahin, İrfan Oğuz; Turgut, Namigar

doi:10.22541/au.158921502.21778694

Cited by 11 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this study, mean of LVEF was statistically lower among severe patients than moderate and mild cases (P=0.032), mean EF in mild cases ranged from (62-71%), mean EF in moderate cases ranged from (54-74%), mean EF in severe cases ranged from (40-75%). These findings came in agreement Barman et al (20) that enrolled 90 patients hospitalized for COVID-19, Patients in the severe group had a lower LVEF than those in the non-severe group, according to the study (LVEF, 61.9% ± 4.8 vs 54.0 ± 9.8% P<0.001).…”

Section: Discussionsupporting

confidence: 90%

“…Males and females had no statistically significant differences in illness severity, as 69.2% of male were in severe status vs 56.3% of female in severe status. Barman et al (20) enrolled 90 COVID-19 patients, 54% of patients were males and 47% of patients were females and showed that men and women had no statistically significant differences in the severity of symptoms (p=0.524).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cardiovascular Manifestations in Echocardiography in Patients Recently Recovered From COVID-19 Infection

Bensaeed¹,

El-Sherbiny²,

Shereef³

et al. 2022

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: As a major source of morbidity and mortality, COVID-19 (coronavirus disease 2019) has developed. In both COVID-19 and other pneumonias, high T/I troponin levels may indicate damage to the heart. Objective: ln order to expand our understanding of COVID-19 cardiology effects, as well as provide insights into the features of people who are more prone to cardiovascular diseases. Methods: At isolation hospital in Zagazig, and the isolation hospital in Tripoli, Libya, 42 COVID-19 positive subjects were studied for their echocardiographic parameters, the study was carried out from March 5 th , 2021, to September 4 th 2021. Results: Arrhythmias, myocardial infarctions, valvular dysfunction, pulmonary hypertension, and right ventricular dysfunction (RVD) were found to have no statistically significant association to the severity of COVID-19. Mean of left ventricular ejection fraction (LVEF) was statistically lower among severe COVID-19 patients than moderate and mild cases but means of RV diameter (mm) was statistically higher among severe COVID-19 patients than moderate and mild cases, mean of fractional area change (FAC) was statistically lower in severe COVID-19 patients. Pulmonary hypertension was the second most common echocardiographic finding (38% of patients). There was no statistically significant difference in pulmonary hypertension across COVID-19 patients in relation to the severity (P=0.211). Conclusion:Echocardiography can provide us with important information which can help in managing of patients with COVID-19 while we must consider contamination risks as well as transmission of diseases.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Cardiovascular Manifestations in Echocardiography in Patients Recently Recovered From COVID-19 Infection

Bensaeed¹,

El-Sherbiny²,

Shereef³

et al. 2022

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

show abstract

“…[47] Studies by Zhou et al [1] found that patients with cardiac injury had lower lymphocyte counts and higher levels of inflammatory biomarkers compared with those without cardiac injury. [27] Studies by D'Alto et al [22,24,27,29,32,34,47,48] also found significant differences in myocardial enzyme levels in nonsurvivors compared with survivors, suggesting that these enzyme levels may have prognostic potential and affect pooled effect estimates. Therefore, the present work did not find a statistically significant difference; this may be related to the limited number of patients and the varying severity of the disease cases that were included in this meta-analysis.…”

Section: Discussionmentioning

confidence: 99%

Low tricuspid annular plane systolic excursion is associated with a poor outcome in patients with COVID-19

Tian

Liu

et al. 2022

Medicine

View full text Add to dashboard Cite

Background: This systematic review and meta-analysis aimed to assess whether tricuspid annular plane systolic excursion (TAPSE) could be used as a prognostic tool in patients with coronavirus disease 19 .Methods: Studies on the relationship between TAPSE and COVID-19 since February 2021. Standardized mean difference (SMD) and 95% confidence intervals were used to assess the effect size. The potential for publication bias was assessed using a contourenhanced funnel plot and Egger test. A meta-regression was performed to assess if the difference in TAPSE between survivors and nonsurvivors was affected by age, sex, hypertension or diabetes.Results: Sixteen studies comprising 1579 patients were included in this meta-analysis. TAPSE was lower in nonsurvivors (SMD À3.24 (À4.23, À2.26), P < .00001; I 2 = 71%), and a subgroup analysis indicated that TAPSE was also lower in critically ill patients (SMD À3.85 (À5.31, À2.38,), P < .00001; I 2 = 46%). Heterogeneity was also significantly reduced, I 2 < 50%. Pooled results showed that patients who developed right ventricular dysfunction had lower TAPSE (SMD À5.87 (À7.81, À3.92), P = .004; I 2 = 82%). There was no statistically significant difference in the TAPSE of patients who sustained a cardiac injury vs those who did not (SMD À1.36 (À3.98, 1.26), P = .31; I 2 = 88%). No significant publication bias was detected (P = .8147) but the heterogeneity of the included studies was significant. A meta-regression showed that heterogeneity was significantly greater when the incidence of hypertension was <50% (I 2 = 91%) and that of diabetes was <30% (I 2 = 85%). Conclusion:Low TAPSE levels are associated with poor COVID-19 disease outcomes. TAPSE levels are modulated by disease severity, and their prognostic utility may be skewed by pre-existing patient comorbidities.

show abstract

“…Several other studies have found LVEF to be a predictor of mortality in patients admitted for COVID-19. Diaz et al reported that LVEF was associated independently with mortality within 60-days of admission 29 www.nature.com/scientificreports/ to the non-severe group and controls 30,31 . Assessment of LVEF in all of these studies was performed during the acute phase of the disease, and previous heart function status either remained unknown or was not taken into consideration when determining the clinical prognosis, regardless of whether or not there was cardiac damage during the infection.…”

Section: Discussionmentioning

confidence: 99%

Impact of previous cardiac function status assessed by echocardiography on the outcome of COVID-19

Carrión

Olmos

Luaces

et al. 2022

Sci Rep

View full text Add to dashboard Cite

More than 91,000 fatalities due to Coronavirus Disease 2019 (COVID-19) have occurred in Spain. Several factors are associated with increased mortality in this disease, including cardiovascular risk factors (CVRF). However, information on the cardiac function of patients prior to the onset of COVID-19 is scarce and the potential impact it may have is uncertain. The aim of the EchoVID study was to describe the potential association between CVRF and cardiac function status prior to SARS-CoV-2 infection and in-hospital mortality. We studied clinical characteristics and cardiac function of patients admitted during the first wave of COVID-19. All patients had a transthoracic echocardiogram performed in the previous 12 months prior to diagnosis; conventional systolic and diastolic function parameters were analyzed. Logistic regression analysis was performed to identify predictors of in-hospital mortality. We included 296 individuals. Median age was higher in the group of patients who died (81.0 vs 76.1 years; p = 0.007). No significant differences were found in CVRF. Survivors were more frequently receiving anticoagulation therapy (52.9% vs 70.8%; p = 0.003). LVEF, although preserved on average in both groups, was significantly lower in the group of deceased patients (56.9% vs 61.1%; p = 0.017). Average E/e′ ratio was higher in the deceased group (11.1 vs 10.1; p = 0.049). Five variables were found to be independently associated with in-hospital mortality due to COVID-19: Age, male gender, LVEF, E/e′ ratio and anticoagulation therapy. A model including these variables had an area under the ROC curve of 0.756 (CI 0.669–0.843). The echocardiographic variables included in the model significantly improved the discriminative power, compared to a model including only demographic data. Left ventricular ejection fraction and E/e′ ratio prior to SARS-CoV-2 infection are two easily-obtained echocardiographic parameters that provide additional prognostic information over clinical factors when assessing patients admitted for SARS-CoV-2 infection.

show abstract

Echocardiographic features of patients with COVID-19 infection: a cross-sectional study

Cited by 11 publications

References 0 publications

Cardiovascular Manifestations in Echocardiography in Patients Recently Recovered From COVID-19 Infection

Cardiovascular Manifestations in Echocardiography in Patients Recently Recovered From COVID-19 Infection

Low tricuspid annular plane systolic excursion is associated with a poor outcome in patients with COVID-19

Impact of previous cardiac function status assessed by echocardiography on the outcome of COVID-19

Contact Info

Product

Resources

About